Renee Whan
University of New South Wales
70 Papers
141 Citations
Renee Whan is an academic researcher from University of New South Wales. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 19, co-authored 60 publications. Previous affiliations of Renee Whan include University of Sydney & Victor Chang Cardiac Research Institute.
Chat about Author
Papers
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis
Claire Vennin,Claire Vennin,Venessa T. Chin,Venessa T. Chin,Sean C. Warren,Sean C. Warren,Morghan C. Lucas,Morghan C. Lucas,David Herrmann,David Herrmann,Astrid Magenau,Astrid Magenau,Pauline Mélénec,Pauline Mélénec,Stacey N. Walters,Stacey N. Walters,Gonzalo del Monte-Nieto,Gonzalo del Monte-Nieto,James R.W. Conway,James R.W. Conway,Max Nobis,Max Nobis,Amr H. Allam,Amr H. Allam,Rachael A. McCloy,Rachael A. McCloy,Nicola Currey,Nicola Currey,Mark Pinese,Mark Pinese,Alice Boulghourjian,Anaiis Zaratzian,Arne A. S. Adam,Celine Heu,Adnan Nagrial,Angela Chou,Angela Chou,Angela Chou,Angela Steinmann,Alison Drury,Danielle Froio,Marc Giry-Laterriere,Marc Giry-Laterriere,Nathanial L. E. Harris,Nathanial L. E. Harris,Tri Giang Phan,Tri Giang Phan,Rohit Jain,Wolfgang Weninger,Wolfgang Weninger,Ewan J. McGhee,Renee Whan,Amber L. Johns,Jaswinder S. Samra,Lorraine A. Chantrill,Lorraine A. Chantrill,Anthony J. Gill,Maija R.J. Kohonen-Corish,Maija R.J. Kohonen-Corish,Maija R.J. Kohonen-Corish,Richard P. Harvey,Richard P. Harvey,Andrew V. Biankin,Andrew V. Biankin,T.R. Jeffry Evans,Kurt I. Anderson,Shane T. Grey,Shane T. Grey,Christopher J. Ormandy,Christopher J. Ormandy,David Gallego-Ortega,David Gallego-Ortega,Yingxiao Wang,Michael S. Samuel,Owen J. Sansom,Andrew Burgess,Andrew Burgess,Thomas R. Cox,Thomas R. Cox,Jennifer P. Morton,Marina Pajic,Marina Pajic,Paul Timpson,Paul Timpson +83 more
TL;DR: A graded response to priming is demonstrated in stratified patient-derived tumors, indicating that fine-tuned tissue manipulation before chemotherapy may offer opportunities in both primary and metastatic targeting of pancreatic cancer.
Using Fluorescence Lifetime Imaging Microscopy to Monitor Theranostic Nanoparticle Uptake and Intracellular Doxorubicin Release
Johan Sebastian Basuki,Hien Tt Duong,Alexander Macmillan,Rafael B. Erlich,Lars Esser,Lars Esser,Mia C. Akerfeldt,Renee Whan,Maria Kavallaris,Cyrille Boyer,Thomas P. Davis +10 more
TL;DR: A significant change in the transverse relaxivity properties of the IONPs, going from 220 to 390 mM(-1) s(-1), in the presence or absence of conjugated DOX, may be exploited in future theranostic applications.
171
Tracing the Fate of Limbal Epithelial Progenitor Cells in the Murine Cornea
N. Di Girolamo,Samantha Bobba,Vanisri Raviraj,Naomi C. Delic,Iveta Slapetova,Philip R. Nicovich,Gary M. Halliday,Denis Wakefield,Renee Whan,J.G. Lyons +9 more
TL;DR: This model represents a powerful new resource to monitor SC kinetics and fate choice under homeostatic conditions, and may assist in assessing clonal evolution during corneal development, aging, wound‐healing, disease, and following transplantation.
149
TMEM41B and VMP1 are scramblases and regulate the distribution of cholesterol and phosphatidylserine
Yang Emma Li,Yichang Wang,Ximing Du,Tizhong Zhang,Hoi Yin Mak,Sarah E. Hancock,Holly P. McEwen,Holly P. McEwen,Elvis Pandzic,Renee Whan,Yvette Celine Aw,Ivan Lukmantara,Yiqiong Yuan,Xiuju Dong,Anthony S. Don,Anthony S. Don,Nigel Turner,Shiqian Qi,Hongyuan Yang +18 more
TL;DR: In this article, the authors show that TMEM41B and VMP1 are phospholipid scramblases whose deficiency impairs the normal cellular distribution of cholesterol and phosphatidylserine.
125
Dextran-based doxorubicin nanocarriers with improved tumor penetration
Sharon M. Sagnella,Hien T. T. Duong,Alexander Macmillan,Cyrille Boyer,Renee Whan,Joshua A. McCarroll,Thomas P. Davis,Thomas P. Davis,Maria Kavallaris +8 more
TL;DR: The ald-dex-dox nanocarriers represent a promising therapeutic delivery system for the treatment of solid tumors due to their unique enhanced penetration ability combined with their improved efficacy over the parent drug in 3D.
121